![Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications - ScienceDirect Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666328722000360-gr1.jpg)
Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications - ScienceDirect
![HISTAL DC DECONGESTANT ANTIHISTAMINE FAST RELIEF OF NASAL CONGESTION RUNNY NOSE SNEEZING ITCHY WATERY EYES SYRUP 125ML - Kappa Drugs HISTAL DC DECONGESTANT ANTIHISTAMINE FAST RELIEF OF NASAL CONGESTION RUNNY NOSE SNEEZING ITCHY WATERY EYES SYRUP 125ML - Kappa Drugs](https://www.kappadrugs.com/store/wp-content/uploads/2021/09/091595600102-1-1.jpg)
HISTAL DC DECONGESTANT ANTIHISTAMINE FAST RELIEF OF NASAL CONGESTION RUNNY NOSE SNEEZING ITCHY WATERY EYES SYRUP 125ML - Kappa Drugs
Discovery of κ Opioid Receptor (KOR)-Selective d-Tetrapeptides with Improved In Vivo Antinociceptive Effect after Peripheral Administration | ACS Medicinal Chemistry Letters
![Cells | Free Full-Text | Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes Cells | Free Full-Text | Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes](https://pub.mdpi-res.com/cells/cells-10-03026/article_deploy/html/images/cells-10-03026-ag-550.jpg?1636362938)
Cells | Free Full-Text | Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes
![A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422006870-ga1.jpg)
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
![Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.9b00195/asset/images/large/cn-2019-00195v_0008.jpeg)
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
![Histamine and antihistamines modulate dexamethasone-induced expression... | Download Scientific Diagram Histamine and antihistamines modulate dexamethasone-induced expression... | Download Scientific Diagram](https://www.researchgate.net/publication/285782344/figure/fig3/AS:303487863803918@1449368553689/Histamine-and-antihistamines-modulate-dexamethasone-induced-expression-of-endogenous.png)
Histamine and antihistamines modulate dexamethasone-induced expression... | Download Scientific Diagram
![Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications | Semantic Scholar Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/080edb15221752b60d2283df6b45317239afa3ad/4-Figure2-1.png)
Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications | Semantic Scholar
![IJMS | Free Full-Text | Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine, by Suppressing TAK1 in AP-1 Pathway IJMS | Free Full-Text | Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine, by Suppressing TAK1 in AP-1 Pathway](https://pub.mdpi-res.com/ijms/ijms-23-03986/article_deploy/html/images/ijms-23-03986-g001.png?1649233188)
IJMS | Free Full-Text | Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine, by Suppressing TAK1 in AP-1 Pathway
![Amazon.com: Sundhed Natural Pure Quercetin with Bromelain & Bioperine - Repisratory Health, Immune Support, Anti-oxidant, Anti-inflammatory Action Capsules : Health & Household Amazon.com: Sundhed Natural Pure Quercetin with Bromelain & Bioperine - Repisratory Health, Immune Support, Anti-oxidant, Anti-inflammatory Action Capsules : Health & Household](https://m.media-amazon.com/images/I/71TZmV2LkZS._AC_UF1000,1000_QL80_.jpg)
Amazon.com: Sundhed Natural Pure Quercetin with Bromelain & Bioperine - Repisratory Health, Immune Support, Anti-oxidant, Anti-inflammatory Action Capsules : Health & Household
![Loratadine, an antihistamine drug, exhibits anti-inflammatory activity through suppression of the NF-kB pathway - ScienceDirect Loratadine, an antihistamine drug, exhibits anti-inflammatory activity through suppression of the NF-kB pathway - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295220301775-ga1.jpg)
Loratadine, an antihistamine drug, exhibits anti-inflammatory activity through suppression of the NF-kB pathway - ScienceDirect
![Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.9b00195/asset/images/medium/cn-2019-00195v_0001.gif)
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
![Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpp.2017.205/MediaObjects/41386_2018_Article_BFnpp2017205_Fig1_HTML.jpg)